Skip to main content


3DR Labs, an Accumen Company, Announces a New Partnership with Imbio to bring its AI-based Lung Imaging Technology to Health Systems Nationally

Accumen is helping healthcare get better, faster. Today, 3DR Labs, an Accumen Company, announced that it is now offering an artificial intelligence (AI) solution for diagnosing chronic lung disease through a new partnership with Imbio. 3DR Labs customers will have access to Imbio’s AI imaging technology effective immediately.

Read More

Aidoc and Imbio partner to provide an industry first AI solution to prioritize suspected pulmonary embolism and automatically calculate RV/LV ratio

Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and treatment.

Read More